Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 642-915-3 | N-(3 chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2 (methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine bis(4 methylbenzenesulfonate) monohydrate | 388082-78-8 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Aquatic Chronic 4 | H413 | H413 |
State/Form
|
2 | View details | ||||||
| Repr. 1B | H360 (H360D) | H360 (D) |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
| Lact. | H362 | H362 | |||||||||
| STOT RE 2 | H373 (other:unknown) | H373 (unkown) | |||||||||
| Aquatic Chronic 4 | H413 | H413 | |||||||||
| Repr. 1B | H360 | H360 |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
| STOT RE 1 | H372 (Immune system) (oral) | H372 | |||||||||
| H360 |
GHS01 Dgr |
State/Form
|
1 | View details | |||||||
| STOT RE 1 | H372 (other:Liver, He...) | H372 | |||||||||
| H413 | |||||||||||
| Skin Irrit. 2 | H315 | H315 |
GHS07 GHS09 Wng |
State/Form
|
1 | View details | |||||
| Eye Irrit. 2 | H319 | H319 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | |||||||||
Number of Aggregated Notifications: 5